SALUBRISBIO Trademark

Trademark Overview


On Wednesday, April 26, 2017, a trademark application was filed for SALUBRISBIO with the United States Patent and Trademark Office. The USPTO has given the SALUBRISBIO trademark a serial number of 87425888. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2019. This trademark is owned by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.. The SALUBRISBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, fo...
salubrisbio

General Information


Serial Number87425888
Word MarkSALUBRISBIO
Filing DateWednesday, April 26, 2017
Status700 - REGISTERED
Status DateTuesday, May 14, 2019
Registration Number5748146
Registration DateTuesday, May 14, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements


Description of MarkThe mark consists of stylized word of "SalubrisBio".
Goods and ServicesPharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFutian Dist., Shenzhen 518040
CN

Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFutian Dist., Shenzhen 518040
CN

Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFutian Dist., Shenzhen 518040
CN

Trademark Events


Event DateEvent Description
Thursday, July 27, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, April 29, 2017NEW APPLICATION ENTERED
Wednesday, May 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 24, 2017ASSIGNED TO EXAMINER
Thursday, July 27, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, July 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 14, 2018SOU EXTENSION 1 FILED
Monday, June 18, 2018ABANDONMENT - NO USE STATEMENT FILED
Monday, June 18, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, July 17, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 17, 2018PETITION TO REVIVE-GRANTED
Tuesday, July 17, 2018SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 18, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, September 6, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 21, 2018SOU EXTENSION 1 GRANTED
Saturday, September 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 5, 2018ASSIGNED TO PETITION STAFF
Monday, September 24, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, October 9, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, November 14, 2018NOTICE OF ALLOWANCE CANCELLED
Monday, December 17, 2018ABANDONMENT - NO USE STATEMENT FILED
Monday, December 17, 2018ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, January 22, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 22, 2019REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Wednesday, January 23, 20191(B) BASIS DELETED; NEW BASIS REQUESTED
Friday, January 25, 2019NOTICE OF REINSTATEMENT MAILED
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED